189 related articles for article (PubMed ID: 36978160)
1. Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders.
Sakinyte K; Holmberg C
BMC Psychiatry; 2023 Mar; 23(1):207. PubMed ID: 36978160
[TBL] [Abstract][Full Text] [Related]
2. Clinical validity of the 12-item WHODAS-2.0 in a naturalistic sample of outpatients with psychotic disorders.
Holmberg C; Gremyr A; Torgerson J; Mehlig K
BMC Psychiatry; 2021 Mar; 21(1):147. PubMed ID: 33691655
[TBL] [Abstract][Full Text] [Related]
3. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.
Carpiniello B; Pinna F; Manchia M; Tusconi M; Cavallaro R; Bosia M
Schizophr Res; 2022 Jan; 239():34-41. PubMed ID: 34839071
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room.
Montoya A; Valladares A; Lizán L; San L; Escobar R; Paz S
Health Qual Life Outcomes; 2011 Mar; 9():18. PubMed ID: 21447155
[TBL] [Abstract][Full Text] [Related]
5. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
[TBL] [Abstract][Full Text] [Related]
6. Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances.
Pinna F; Bosia M; Cavallaro R; Carpiniello B
Schizophr Res Cogn; 2014 Dec; 1(4):187-192. PubMed ID: 29379752
[TBL] [Abstract][Full Text] [Related]
7. Item response analysis of the Positive and Negative Syndrome Scale.
Santor DA; Ascher-Svanum H; Lindenmayer JP; Obenchain RL
BMC Psychiatry; 2007 Nov; 7():66. PubMed ID: 18005449
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
9. Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders.
Pinna F; Deriu L; Diana E; Perra V; Randaccio RP; Sanna L; Tusconi M; Carpiniello B;
Ann Gen Psychiatry; 2015; 14():6. PubMed ID: 25699085
[TBL] [Abstract][Full Text] [Related]
10. French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms.
Favrod J; Rexhaj S; Ferrari P; Bardy S; Hayoz C; Morandi S; Bonsack C; Giuliani F
BMC Psychiatry; 2012 Sep; 12():161. PubMed ID: 23020603
[TBL] [Abstract][Full Text] [Related]
11. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
[TBL] [Abstract][Full Text] [Related]
12. Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders.
Pinna F; Tusconi M; Bosia M; Cavallaro R; Carpiniello B;
BMC Psychiatry; 2013 Sep; 13():235. PubMed ID: 24294839
[TBL] [Abstract][Full Text] [Related]
13. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
El Gharbi I; Chhoumi M; Mechri A
Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
[TBL] [Abstract][Full Text] [Related]
14. Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility.
Ritsner MS; Mar M; Arbitman M; Grinshpoon A
Psychiatry Res; 2013 Jun; 208(1):1-8. PubMed ID: 23582209
[TBL] [Abstract][Full Text] [Related]
15. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
16. Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16years follow-up study.
Marchesi C; Affaticati A; Monici A; De Panfilis C; Ossola P; Tonna M
Compr Psychiatry; 2014 May; 55(4):778-84. PubMed ID: 24461689
[TBL] [Abstract][Full Text] [Related]
17. Associations of living arrangements with symptoms and functioning in schizophrenia.
Ang MS; Rekhi G; Lee J
BMC Psychiatry; 2021 Oct; 21(1):497. PubMed ID: 34635064
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Portuguese version of the Psychotic Symptom Rating Scales (PSYRATS).
Telles-Correia D; Barbosa-Rocha N; Gama-Marques J; Moreira AL; Alves-Moreira C; Saraiva S; Antunes F; Almeida C; Machado S; Haddock G
Actas Esp Psiquiatr; 2017 Mar; 45(2):56-61. PubMed ID: 28353290
[TBL] [Abstract][Full Text] [Related]
19. Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.
Garcia-Alvarez L; Garcia-Portilla MP; Saiz PA; Fonseca-Pedrero E; Bobes-Bascaran MT; Gomar J; Muñiz J; Bobes J
Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(3):169-175. PubMed ID: 29628403
[TBL] [Abstract][Full Text] [Related]
20. Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia.
Nielsen CM; Kølbæk P; Dines D; Pedersen ML; Danielsen AA; Holmgård C; Wissing S; Esbøl AM; Fuglsang NFB; Nguyen TD; Mors O; Opler M; Correll CU; Østergaard SD
J Psychopharmacol; 2022 Nov; 36(11):1208-1217. PubMed ID: 36268705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
